Akt inhibits Myt1 in the signalling pathway that leads to meiotic G2/M-phase transition

Eiichi Okumura1, Takeshi Fukuhara, Hitoshi Yoshida

  • 1Laboratory of Cell and Developmental Biology, Graduate School of Bioscience, Tokyo Institute of Technology, Nagatsuta, Midoriku, Yokohama 226-8501, Japan.

Nature Cell Biology
|January 22, 2002
PubMed

Insights

The protein kinase Akt phosphorylates and downregulates Myt1, a Wee1 family kinase. This action initiates M-phase entry by activating cyclin B-Cdc2 kinase during the G2/M transition.

Area of Science:

  • Cell Biology
  • Molecular Biology
  • Biochemistry

Background:

  • M-phase entry in eukaryotes is regulated by cyclin B-Cdc2 kinase.
  • Wee1 family kinases inactivate cyclin B-Cdc2, while Cdc25C phosphatase activates it.
  • The mechanism reversing Wee1 and Cdc25C activity at M-phase entry is unknown.

Purpose of the Study:

  • To elucidate the mechanism regulating the switch in Wee1 and Cdc25C activity at the G2/M transition.
  • To identify novel regulators of M-phase initiation.

Main Methods:

  • Studied starfish (Asterina pectinifera) oocytes.
  • Investigated the role of Akt kinase in regulating Myt1, a Wee1 family member.
  • Analyzed the phosphorylation and activity of Myt1 and cyclin B-Cdc2.

Main Results:

  • Akt (protein kinase B) phosphorylates and downregulates Myt1 in starfish oocytes.
  • This action shifts the balance of regulator activities, favoring Cdc25C over Wee1 family kinases.
  • The findings demonstrate Akt's role in initiating cyclin B-Cdc2 activation at the meiotic G2/M transition.

Conclusions:

  • Myt1 is a novel substrate for Akt.
  • Akt functions as a key initiator of M-phase entry by downregulating Wee1 family kinases.
  • This study reveals a new regulatory pathway controlling cell cycle progression.

Related Concept Videos

Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Inhibition of CDK Activity02:34

Inhibition of CDK Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
M-Cdk Drives Transition Into Mitosis02:15

M-Cdk Drives Transition Into Mitosis

Checkpoints throughout the cell cycle serve as safeguards and gatekeepers, allowing the cell cycle to progress in favorable conditions and slow or halt it in problematic ones. This regulation is known as the cell cycle control system.
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...